Pyrovalerone
From Wikipedia, the free encyclopedia
Pyrovalerone (Centroton, Thymergix) is a stimulant drug developed in the late 1960s and used in France and some other European countries. This drug is now rarely prescribed due to problems with abuse and dependence [1] , but is still rarely prescribed either as an appetite suppresant or for treating chronic fatigue and lethargy. [2] Side effects of pyrovalerone include loss of appetite, anxiety, insomnia and tremor. Withdrawal sydrome following abuse causes depression. [3] Pyrovalerone is a Schedule 5 drug in the USA.
1-(4-methylphenyl)-2-(1-pyrrolidinyl)pentan-1-one
CAS# 1147-62-2 (pyrovalerone hydrochloride); 3563-49-3 (pyrovalerone freebase)
- ^ Deniker P, Loo H, Cuche H, Roux JM. Abuse of pyrovalerone by drug addicts. Annales Medico-Psychologiques (Paris) 1975 Nov;2(4):745-8.
- ^ Gardos G, Cole JO. Evaluation of pyrovalerone in chronically fatigued volunteers. Current Therapeutic Research, Clinical and Experimental. 1971 Oct;13(10):631-5.
- ^ http://www.biam2.org/www/Etr8623.html
Adrafinil, Amphetamine (speed), Armodafinil, Caffeine, Cocaine, Ephedrine, Epinephrine (adrenaline), MDMA, Methylphenidate, Modafinil, Nicotine
See also Sympathomimetic amines
